SC 13G Filing

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

January 25, 2024

Accession Number

0001086364-24-003204

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →